Selected research
Industry Research
Clinical Trial Laboratory Testing Industry Research Report 2026
Market perspective
The global Clinical Trial Laboratory Testing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Clinical Trial Laboratory Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Clinical Trial Laboratory Testing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Clinical Trial Laboratory Testing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Clinical Trial Laboratory Testing include SGS, LabCorp, Cerba Research, IQVIA Q² Solutions, Eurofins, Charles River, ACM Global Laboratories, Australian Clinical Labs and PPD, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Clinical Trial Laboratory Testing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Clinical Trial Laboratory Testing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Clinical Trial Laboratory Testing Market by Company
SGS
LabCorp
Cerba Research
IQVIA Q² Solutions
Eurofins
Charles River
ACM Global Laboratories
Australian Clinical Labs
PPD
Almac Group
Mayo Clinic
LabConnect
Pharmaron
Frontage
WuXi AppTec
CTI
KingMed
CIRS
Clinical Trial Laboratory Testing Segment by Type
Central Laboratory Services
Clinical Bioanalysis Services
Genomics and Biomarkers
Other Services
Clinical Trial Laboratory Testing Segment by Application
Pharmaceuticals
Biotechnology
Medical Devices
Other
Clinical Trial Laboratory Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Clinical Trial Laboratory Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Clinical Trial Laboratory Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Clinical Trial Laboratory Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Clinical Trial Laboratory Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Central Laboratory Services
- Clinical Bioanalysis Services
- Genomics and Biomarkers
- Other Services
Applications
- Pharmaceuticals
- Biotechnology
- Medical Devices
- Other
Companies covered
- SGS
- LabCorp
- Cerba Research
- IQVIA Q² Solutions
- Eurofins
- Charles River
- ACM Global Laboratories
- Australian Clinical Labs
- PPD
- Almac Group
- Mayo Clinic
- LabConnect
- Pharmaron
- Frontage
- WuXi AppTec
- CTI
- KingMed
- CIRS
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Clinical Trial Laboratory Testing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Central Laboratory Services
- 2.2.3 Clinical Bioanalysis Services
- 2.2.4 Genomics and Biomarkers
- 2.2.5 Other Services
- 2.3 Clinical Trial Laboratory Testing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceuticals
- 2.3.3 Biotechnology
- 2.3.4 Medical Devices
- 2.3.5 Other
- 2.4 Assumptions and Limitations
3 Clinical Trial Laboratory Testing Breakdown Data by Type
- 3.1 Global Clinical Trial Laboratory Testing Historic Market Size by Type (2021-2026)
- 3.2 Global Clinical Trial Laboratory Testing Forecasted Market Size by Type (2027-2032)
4 Clinical Trial Laboratory Testing Breakdown Data by Application
- 4.1 Global Clinical Trial Laboratory Testing Historic Market Size by Application (2021-2026)
- 4.2 Global Clinical Trial Laboratory Testing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Clinical Trial Laboratory Testing Market Perspective (2021-2032)
- 5.2 Global Clinical Trial Laboratory Testing Growth Trends by Region
- 5.2.1 Global Clinical Trial Laboratory Testing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Clinical Trial Laboratory Testing Historic Market Size by Region (2021-2026)
- 5.2.3 Clinical Trial Laboratory Testing Forecasted Market Size by Region (2027-2032)
- 5.3 Clinical Trial Laboratory Testing Market Dynamics
- 5.3.1 Clinical Trial Laboratory Testing Industry Trends
- 5.3.2 Clinical Trial Laboratory Testing Market Drivers
- 5.3.3 Clinical Trial Laboratory Testing Market Challenges
- 5.3.4 Clinical Trial Laboratory Testing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Clinical Trial Laboratory Testing Players by Revenue
- 6.1.1 Global Top Clinical Trial Laboratory Testing Players by Revenue (2021-2026)
- 6.1.2 Global Clinical Trial Laboratory Testing Revenue Market Share by Players (2021-2026)
- 6.2 Global Clinical Trial Laboratory Testing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Clinical Trial Laboratory Testing Head Office and Area Served
- 6.4 Global Clinical Trial Laboratory Testing Players, Product Type & Application
- 6.5 Global Clinical Trial Laboratory Testing Manufacturers Established Date
- 6.6 Global Clinical Trial Laboratory Testing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Clinical Trial Laboratory Testing Market Size (2021-2032)
- 7.2 North America Clinical Trial Laboratory Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Clinical Trial Laboratory Testing Market Size by Country (2021-2026)
- 7.4 North America Clinical Trial Laboratory Testing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Clinical Trial Laboratory Testing Market Size (2021-2032)
- 8.2 Europe Clinical Trial Laboratory Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Clinical Trial Laboratory Testing Market Size by Country (2021-2026)
- 8.4 Europe Clinical Trial Laboratory Testing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Clinical Trial Laboratory Testing Market Size (2021-2032)
- 9.2 Asia-Pacific Clinical Trial Laboratory Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Clinical Trial Laboratory Testing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Clinical Trial Laboratory Testing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Clinical Trial Laboratory Testing Market Size (2021-2032)
- 10.2 South America Clinical Trial Laboratory Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Clinical Trial Laboratory Testing Market Size by Country (2021-2026)
- 10.4 South America Clinical Trial Laboratory Testing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Clinical Trial Laboratory Testing Market Size (2021-2032)
- 11.2 Middle East & Africa Clinical Trial Laboratory Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Clinical Trial Laboratory Testing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Clinical Trial Laboratory Testing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 SGS
- 12.1.1 SGS Company Information
- 12.1.2 SGS Business Overview
- 12.1.3 SGS Revenue in Clinical Trial Laboratory Testing Business (2021-2026)
- 12.1.4 SGS Clinical Trial Laboratory Testing Product Portfolio
- 12.1.5 SGS Recent Developments
- 12.2 LabCorp
- 12.2.1 LabCorp Company Information
- 12.2.2 LabCorp Business Overview
- 12.2.3 LabCorp Revenue in Clinical Trial Laboratory Testing Business (2021-2026)
- 12.2.4 LabCorp Clinical Trial Laboratory Testing Product Portfolio
- 12.2.5 LabCorp Recent Developments
- 12.3 Cerba Research
- 12.3.1 Cerba Research Company Information
- 12.3.2 Cerba Research Business Overview
- 12.3.3 Cerba Research Revenue in Clinical Trial Laboratory Testing Business (2021-2026)
- 12.3.4 Cerba Research Clinical Trial Laboratory Testing Product Portfolio
- 12.3.5 Cerba Research Recent Developments
- 12.4 IQVIA Q² Solutions
- 12.4.1 IQVIA Q² Solutions Company Information
- 12.4.2 IQVIA Q² Solutions Business Overview
- 12.4.3 IQVIA Q² Solutions Revenue in Clinical Trial Laboratory Testing Business (2021-2026)
- 12.4.4 IQVIA Q² Solutions Clinical Trial Laboratory Testing Product Portfolio
- 12.4.5 IQVIA Q² Solutions Recent Developments
- 12.5 Eurofins
- 12.5.1 Eurofins Company Information
- 12.5.2 Eurofins Business Overview
- 12.5.3 Eurofins Revenue in Clinical Trial Laboratory Testing Business (2021-2026)
- 12.5.4 Eurofins Clinical Trial Laboratory Testing Product Portfolio
- 12.5.5 Eurofins Recent Developments
- 12.6 Charles River
- 12.6.1 Charles River Company Information
- 12.6.2 Charles River Business Overview
- 12.6.3 Charles River Revenue in Clinical Trial Laboratory Testing Business (2021-2026)
- 12.6.4 Charles River Clinical Trial Laboratory Testing Product Portfolio
- 12.6.5 Charles River Recent Developments
- 12.7 ACM Global Laboratories
- 12.7.1 ACM Global Laboratories Company Information
- 12.7.2 ACM Global Laboratories Business Overview
- 12.7.3 ACM Global Laboratories Revenue in Clinical Trial Laboratory Testing Business (2021-2026)
- 12.7.4 ACM Global Laboratories Clinical Trial Laboratory Testing Product Portfolio
- 12.7.5 ACM Global Laboratories Recent Developments
- 12.8 Australian Clinical Labs
- 12.8.1 Australian Clinical Labs Company Information
- 12.8.2 Australian Clinical Labs Business Overview
- 12.8.3 Australian Clinical Labs Revenue in Clinical Trial Laboratory Testing Business (2021-2026)
- 12.8.4 Australian Clinical Labs Clinical Trial Laboratory Testing Product Portfolio
- 12.8.5 Australian Clinical Labs Recent Developments
- 12.9 PPD
- 12.9.1 PPD Company Information
- 12.9.2 PPD Business Overview
- 12.9.3 PPD Revenue in Clinical Trial Laboratory Testing Business (2021-2026)
- 12.9.4 PPD Clinical Trial Laboratory Testing Product Portfolio
- 12.9.5 PPD Recent Developments
- 12.10 Almac Group
- 12.10.1 Almac Group Company Information
- 12.10.2 Almac Group Business Overview
- 12.10.3 Almac Group Revenue in Clinical Trial Laboratory Testing Business (2021-2026)
- 12.10.4 Almac Group Clinical Trial Laboratory Testing Product Portfolio
- 12.10.5 Almac Group Recent Developments
- 12.11 Mayo Clinic
- 12.11.1 Mayo Clinic Company Information
- 12.11.2 Mayo Clinic Business Overview
- 12.11.3 Mayo Clinic Revenue in Clinical Trial Laboratory Testing Business (2021-2026)
- 12.11.4 Mayo Clinic Clinical Trial Laboratory Testing Product Portfolio
- 12.11.5 Mayo Clinic Recent Developments
- 12.12 LabConnect
- 12.12.1 LabConnect Company Information
- 12.12.2 LabConnect Business Overview
- 12.12.3 LabConnect Revenue in Clinical Trial Laboratory Testing Business (2021-2026)
- 12.12.4 LabConnect Clinical Trial Laboratory Testing Product Portfolio
- 12.12.5 LabConnect Recent Developments
- 12.13 Pharmaron
- 12.13.1 Pharmaron Company Information
- 12.13.2 Pharmaron Business Overview
- 12.13.3 Pharmaron Revenue in Clinical Trial Laboratory Testing Business (2021-2026)
- 12.13.4 Pharmaron Clinical Trial Laboratory Testing Product Portfolio
- 12.13.5 Pharmaron Recent Developments
- 12.14 Frontage
- 12.14.1 Frontage Company Information
- 12.14.2 Frontage Business Overview
- 12.14.3 Frontage Revenue in Clinical Trial Laboratory Testing Business (2021-2026)
- 12.14.4 Frontage Clinical Trial Laboratory Testing Product Portfolio
- 12.14.5 Frontage Recent Developments
- 12.15 WuXi AppTec
- 12.15.1 WuXi AppTec Company Information
- 12.15.2 WuXi AppTec Business Overview
- 12.15.3 WuXi AppTec Revenue in Clinical Trial Laboratory Testing Business (2021-2026)
- 12.15.4 WuXi AppTec Clinical Trial Laboratory Testing Product Portfolio
- 12.15.5 WuXi AppTec Recent Developments
- 12.16 CTI
- 12.16.1 CTI Company Information
- 12.16.2 CTI Business Overview
- 12.16.3 CTI Revenue in Clinical Trial Laboratory Testing Business (2021-2026)
- 12.16.4 CTI Clinical Trial Laboratory Testing Product Portfolio
- 12.16.5 CTI Recent Developments
- 12.17 KingMed
- 12.17.1 KingMed Company Information
- 12.17.2 KingMed Business Overview
- 12.17.3 KingMed Revenue in Clinical Trial Laboratory Testing Business (2021-2026)
- 12.17.4 KingMed Clinical Trial Laboratory Testing Product Portfolio
- 12.17.5 KingMed Recent Developments
- 12.18 CIRS
- 12.18.1 CIRS Company Information
- 12.18.2 CIRS Business Overview
- 12.18.3 CIRS Revenue in Clinical Trial Laboratory Testing Business (2021-2026)
- 12.18.4 CIRS Clinical Trial Laboratory Testing Product Portfolio
- 12.18.5 CIRS Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst